Dan Xu

Dan Xu is a skilled Biomarker Clinical Assay Lead with a strong background in implementing complex biomarker strategies across multiple platforms in global clinical trials. They previously worked as a Senior Scientist at Pfizer, overseeing a team and ensuring high-quality assay operations, and began their career as a Research Technician III at the University of Georgia, where they contributed to vaccine development for Chagas disease. Dan holds a degree from The University of Georgia and is passionate about process improvement to expedite treatment options for patients worldwide. Their expertise encompasses communication and collaboration with various stakeholders to drive successful clinical trial outcomes.